TREM2 is associated with AD and neurodegeneration, which leads us to hypothesize that CSF sTREM2 may be a marker of microglial function, and microglial response to amyloid β (Aβ), tau pathology and neurodegeneration. The gene discussed is TREM2; the disease is Alzheimer disease.